Add BrightSurf on Google Email

First 3D-bioprinting of entire active tumor

Researchers at Tel Aviv University successfully printed the first entirely active and viable glioblastoma tumor using a 3D printer. The 3D-bioprinted model includes functional blood vessels that simulate a real tumor, making it a promising tool for predicting treatment efficacy and drug development.

SourceTel-Aviv University·JournalScience Advances·DateAug 18, 2021

Fels and Fox Chase researchers highlight roles of TET2 and DNMT3A mutations in personalized medicine-guided synthetic lethality against leukemia

Fels and Fox Chase researchers found specific TET2 and DNMT3A mutations in leukemia patients that affect DNA repair pathways. These mutations make leukemia cells sensitive to PARP inhibitors, a type of targeted therapy, while others are resistant. The study aims to develop personalized therapies for patients with these mutations.

SourceTemple University Health System·JournalCancer Research·DateAug 13, 2021

Comparing DNA changes in blood stem cells and leukemia cells could help pick out children with high-risk AML

A new study published in Blood Cancer Discovery reveals that children with acute myeloid leukemia (AML) who have more DNA changes in their blood stem cells are more likely to survive. The researchers hope that this finding can be used as a tool to identify high-risk patients and improve treatment outcomes.

SourcePrincess Máxima Center for Pediatric Oncology·JournalBlood Cancer Discovery·TypeExperimental study·DateAug 6, 2021

Following cancer progress in real time

A new test with 'unprecedented early detection power' is being developed by a University of Houston researcher to detect cancer biomarkers in blood. The liquid biopsy method uses exosomes, small vesicles containing surface proteins and genetic materials, to improve the accuracy of measuring minimal residual disease (MRD) in cancer tumors.

Two studies by CU Cancer Center researchers explore link between inflammation and leukemia

Two studies by CU Cancer Center researchers found that chronic inflammation can serve as a key factor in the development of leukemia. Chronic inflammation reduces the fitness of normal cells, hindering their ability to reproduce and creating space for cancer-causing mutations to proliferate. The findings support the theory of adaptive ...

SourceUniversity of Colorado Anschutz Medical Campus·JournalJournal of Experimental Medicine·DateJun 28, 2021

IU research findings could reduce treatment-related complication for blood cancer patients

Researchers at Indiana University School of Medicine have discovered a promising treatment approach for preventing acute graft-versus-host disease, a common complication of blood stem cell transplantation. The study found that using the oral drug sitagliptin reduces the risk of GVHD by inhibiting immune T cell activation.

SourceIndiana University School of Medicine·JournalNew England Journal of Medicine·DateJan 7, 2021

US state government crisis standards of care guidelines

State crisis standards of care (CSC) guidelines in the US allocate scarce healthcare resources among cancer patients, requiring careful consideration of prioritization methods. The guidelines include provisions for blood products and palliative care, highlighting the need for nuanced decision-making in resource allocation.

SourceJAMA Network·JournalJAMA Oncology·DateDec 3, 2020

Study in Nature Medicine shows superior patient outcomes in LLS's Beat AML clinical trial

The study demonstrated a paradigm shift in treating AML, proving that genetic information matching leads to better survival rates than traditional one-size-fits-all treatment. Patients who opted for precision medicine experienced lower early death rates and superior overall survival compared to those receiving standard of care.

SourceOgilvy Public Relations, New York·JournalNature Medicine·DateOct 27, 2020

Cutting cancer off at the head

Researchers have developed a new diagnostic tool that can detect cancer cells in small blood samples and connect them to their original tumor. This method has shown significant correlations between circulating tumor cells and tumor expression levels, allowing for targeted therapeutic agents to be used more accurately.

SourceOsaka City University·JournalCancer Science·DateOct 21, 2020

Hand-held device reads levels of cancer biomarker

Researchers at McMaster University have developed a prototype for a hand-held device that can read the levels of a cancer biomarker, similar to a blood-sugar monitor. The device simplifies cancer testing by allowing patients to collect samples at home and providing accurate results in minutes.

SourceMcMaster University·JournalAngewandte Chemie·DateOct 19, 2020

Blood marker may reduce cancer burden

Researchers at Flinders University have discovered a blood serum microRNA biomarker signature for oropharyngeal squamous cell carcinoma, which may help detect other head and neck cancers. The signature has potential for surveillance, earlier diagnosis, and treatment of head and neck cancer.

SourceFlinders University·JournalJournal of Translational Medicine·DateSep 1, 2020

Study of nearly 10,000 women explores feasibility and safety of multi-cancer blood test

Researchers developed a multi-cancer blood test that detected some cancers, including ovarian cancers, and successfully screened for non-cancer causes before diagnostic tests. The test showed promise as a minimally invasive option to increase cancer detection rates in populations already following standard screening approaches.